The move follows an August 2023 recommendation from the Department of Health and Human Services (HHS) to the U.S. Drug Enforcement Administration (DEA) to reevalutate the drug for potential ...
This DEA rescheduling effort significantly reforms federal marijuana law in many areas of the law but not all areas of the law. This proposed change carries significant implications for medical use, ...